Researchers have profiled the molecular structure and features of a key part of the deadly Nipah virus. Experiments in cells showe how changes in the viral polymerase -- a protein involved in viral ...
Hosted on MSN10h
New Queen's University study shows how coronavirus was introduced and spread across IrelandThe study also evaluated the effectiveness of public health measures, such as travel restrictions, in reducing the spread ...
Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...
Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...
The macaques exposed via the mouth or stomach, however, had limited infection but showed no signs of illness. All the monkeys ...
The study authors say the findings suggest healthcare workers could be "unrecognized reservoirs" of pneumococcus in the ...
In early December, health officials in the Democratic Republic of the Congo, or DRC, announced that an unknown illness had ...
In a major study of 15,000 patients, nearly 89% of ME/CFS cases met the criteria for long Covid - something may patients have ...
The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...
Indeed, a recent study published in the journal Arteriosclerosis, Thrombosis, and Vascular Biology found a prolonged ...
A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 in 2021 are less effective in patients with autoimmune diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback